skip to main content

Opioid choice in renal impairment — RACP Adult Medicine MCQ

Instant feedback + full explanation. One question, done properly.

HardPalliative careOpioid choice in renal impairmentRACP Adult Medicine

A 72-year-old with metastatic prostate cancer and eGFR 18 mL/min/1.73 m2 becomes drowsy and develops myoclonus after repeated morphine escalation. Pain remains severe. What is the best next analgesic strategy?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DReduce or stop morphine, treat reversible contributors and rotate under expert supervision to an opioid with a safer renal metabolite profile

The best answer is “Reduce or stop morphine, treat reversible contributors and rotate under expert supervision to an opioid with a safer renal metabolite profile”. Morphine glucuronides accumulate in advanced kidney impairment and can cause sedation and myoclonus. Management includes hydration or other reversible factors where appropriate, dose reduction or cessation, and carefully calculated rotation—often to fentanyl or another renal-safer option—with close palliative review. Codeine also accumulates, naloxone may reverse dangerous acute toxicity but abolishes analgesia, and untreated severe cancer pain is unacceptable.

Reference: Australian Prescriber: Rational prescribing in community palliative care: https://australianprescriber.tg.org.au/articles/rational-prescribing-in-community-palliative-care.html Kidney Health Australia: CKD Management in Primary Care, 5th edition: https://kidney.org.au/health-professionals/ckd-management-handbook/